Xi-yun Chen

Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer

Dong-sheng Chen, Wei Wei, Zhuo Cheng, 2023, Nature Communications.